News & Updates

Among pregnant women, exposure to mRNA COVID-19 vaccine in the first trimester does not appear to contribute to an increased risk of selected major structural birth defects, according to a retrospective study.

The use of long-acting injectable cabotegravir (CAB-LA) as a pre-exposure prophylaxis (PrEP) during pregnancy appears to be safe and well tolerated in cisgender women, according to the initial data of HPTN* 084 open-label extension (OLE) study presented at AIDS 2024.

Women who experience pre-eclampsia during pregnancy face a heightened risk of vascular dementia later in life, according to the results of a meta-analysis.

Pregnant women with epilepsy face considerably greater risk of severe morbidity as well as maternal and perinatal mortality, according to a study.

Young women who start taking hormonal contraceptives early in life may be at increased risk of endometriosis, as suggested in a study.

Pre-exposure prophylaxis (PrEP) with the antibiotic doxycycline helps to prevent sexually transmitted infections (STIs) in high-risk populations, including female sex workers and HIV-positive men who have sex with men (MSM), according to two small studies.

Pre-existing diabetes has been linked to threefold greater odds of stillbirth and perinatal mortality, with type 2 posing a greater threat than type1 diabetes, according to the results of the meta-analysis.

During induction of anaesthesia in gynaecological laparoscopic surgery, the incidence of propofol injection pain (PIP) and rocuronium‑induced withdrawal movement (RIWM) may predict the severity of postoperative pain and total opioid consumption, a prospective observational study has shown.